Thu, Oct 2, 2014, 4:28 AM EDT - U.S. Markets open in 5 hrs 2 mins

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • swhitemd50 swhitemd50 Nov 14, 2011 8:03 PM Flag

    Absurd numbers

    Looking at the recently updated numbers posted on the Yahoo Finance web site under the heading "analyst estimates," they have Vertex growing at more than 200% this quarter and more than 2100% next year. But the 5 year growth estimate is -214% Apparently, after rapid earnings growth from Incivek over the next year or so, they are predicting a rapid deceleration in earnings to the point of negative earnings. This implies they believe Vertex will lose all revenues from drugs to treat Hep C and no new revenues will be realized from VX770 and other drugs in the Vertex pipeline in the next 5 years. Ridiculous! Checked the Fidelity Investments research web site and it has the same estimates for Vertex earnings growth as Yahoo. As Vertex CEO Mathew Emmens said to Morgan Stanley analyst David Friedman at an investor conference in September, "Do you understand this company? I don't think so. By what I read, I don't think you understand our company. I'm going to do the best I can to prove you wrong again and again..."

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • That's why I said VRTX mgmt are amateurs and do not help the investors. The CEO insults Morgan Stanley. Sure, it might be true but look at the timeframe, VRTX seems to be going down ever since. Funny what analysts know.

      Newsflash to the CEO, get on the analyst good side and help the damn stock and forget your pride.

 
VRTX
107.25-5.06(-4.51%)Oct 1 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.